Shruti Singh
Houston, TXNPI 1467911610
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (47.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Abbott accounts for 69.5% of it on its own, with 18 other manufacturers making up the rest. 2025 is the largest year on record at $15,279, more than ten times the $168 reported in 2022.
Across 109 payments — averaging $218.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$17K
- Medtronic$3K
- Abiomed$1K
- Shockwave Medical, Inc$716
- Boston Scientific$501
- Edwards Lifesciences$303
- plus $1K from 13 others
Across 2 payments — averaging $108.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abiomed$217
What the payments were for
- Grants$11,33348%
- Travel & lodging$6,02125%
- Food & beverage$6,39527%
- Education$1000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 51 | $16,572 |
| Medtronic | 8 | $3,155 |
| Abiomed | 8 | $1,391 |
| Shockwave Medical, Inc | 12 | $716 |
| Boston Scientific | 4 | $501 |
| Edwards Lifesciences | 2 | $303 |
| Heartflow, Inc. | 2 | $154 |
| Amgen | 2 | $145 |
| Penumbra, Inc. | 1 | $141 |
| Teleflex LLC | 2 | $128 |
| Angiodynamics, Inc. | 1 | $125 |
| Inari Medical, Inc. | 1 | $122 |
| Lantheus Medical Imaging, Inc. | 2 | $99 |
| Pfizer | 5 | $98 |
| Johnson & Johnson(2 entities) | 3 | $70 |
| Bridgebio Pharma, Inc. | 2 | $67 |
| Lexicon Pharmaceuticals, Inc. | 1 | $22 |
| Novartis | 1 | $21 |
| AstraZeneca | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XIENCE V$9,000
- OPTIS$3,063
- GALLANT$1,234
- Impella$999
- CARDIOMEMS$992
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$527
- COREVALVE EVOLUT R$282
- SYMPLICITY G3$193
- IN.PACT Admiral$168
- PASCAL$159
- SAPIEN 3 Ultra RESILIA$143
- Indigo System$141
- FFRct$135
- Diamondback Peripheral$133
- Repatha$130
- COMET$128
- AlphaVac$125
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$125
- FLOWTRIEVER CATHETER, S$122
- CT THROMBECTOMY SYSTEM KIT$122
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 15 | $23,741 |
| Metoprolol Succinate | 42 | $847 |
| Ezetimibe | 14 | $610 |
| Atorvastatin Calcium | 36 | $505 |
| Nifedipine ErNifedipine | 14 | $364 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 12 | $299 |
| Lisinopril | 24 | $202 |
| Losartan Potassium | 20 | $192 |
| Rosuvastatin Calcium | 17 | $149 |
| ClopidogrelClopidogrel Bisulfate | 21 | $114 |
| Furosemide | 20 | $108 |
| Amlodipine Besylate | 15 | $80 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $98 | $23,74115 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few providers in Texason file to place this against a meaningful peer group, so we don't.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.